|
|
| Research article summary (published 30 Dec 2006): |
Evolving trends in the long-term treatment of bipolar disorder.
Full Abstract
The episodic and chronic nature of bipolar disorder usually requires long-term treatment in all patients, yet there is an unmet need for well-tolerated and clinically effective maintenance therapy with enhanced patient adherence. Few well-tolerated treatment options are currently available that are both effective in all phases of bipolar disorder and prevent recurrence of episodes. Lithium has well-established efficacy in the prevention of further manic episodes and may also be effective in the prevention of depression and suicide, but safety is a concern due to narrow therapeutic window. For valproate and carbamazepine, data appear much less compelling. Lamotrigine has shown to be effective for long-term prevention of depressive episodes. Controlled studies suggest that atypical antipsychotics may also have mood-stabilizing properties and might become standard for long-term therapy in the new future. The role of psychoeducation in improving adherence to medication in long-term treatment and overall patient outcomes is also crucial.
Author information
Author/s: Vieta, Eduard (E); Rosa, Adriane R (AR);
Affiliation: Bipolar Disorders Program, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain. evieta(-atsign-)clinic.ub.es
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry (World J Biol Psychiatry), published in Scotland. (Language: eng)
Reference: 2007-; vol 8 (issue 1) : pp 4-11
Dates: Created 2007/03/16; Completed 2007/05/02; Revised 2007/11/15;
PMID: 17366344, status: MEDLINE (last retrieved date: 2/18/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Anticonvulsants (0) ; Antimanic Agents (0) ; Antipsychotic Agents (0) ; Lithium Compounds (0)Related articles
These are the most related articles currently in our database:
- Bipolar drug development: are we getting closer to the real world?
29 Sep 2008 - Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study.
30 May 2008 - Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.
20 May 2008 - Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder.
24 Mar 2007 - Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
25 Mar 2007 - Treatment of mania in children and adolescents.
30 Mar 2005 - Recent advances in the treatment of bipolar mania, depression, mixed states, and rapid cycling.
29 Jun 2000 - Lithium, anticonvulsants and suicidal behavior in bipolar disorder.
30 Jan 2003 - The expanding pharmacopoeia for bipolar disorder.
30 Dec 2001 - Long term treatment of bipolar disorder.
28 Feb 1996
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.